RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA

Clinical trials for RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat Hodgkin's lymphoma: boosting immune therapy before transplant

Disease control Recruiting now

This study is testing if adding an immunotherapy drug (atezolizumab) to a standard chemotherapy regimen (BEGEV) works better to prepare patients for a stem cell transplant. It is for adults whose Hodgkin's lymphoma has returned or not responded to their first treatment. The goal …

Matched conditions: RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA

Get alerted when new RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA trials appear

New hope for Tough-to-Treat Hodgkin's lymphoma: boosting immune therapy before transplant